Home › China Rejects Gilead's Sovaldi Patent Application
 

Keywords :   


China Rejects Gilead's Sovaldi Patent Application

2015-06-21 11:47:21| Biotech - Topix.net

China's State Intellectual Property Office has decided to reject a Gilead Sciences, Inc. 's patent application relating to its hepatitis C drug sofosbuvir, marketed as Sovaldi. The rejection could have important implications for Gilead, its generic drug competitors and HCV patients worldwide.

Tags: china application patent rejects

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.07Tropical Storm Beryl Public Advisory Number 29A
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Atlantic Tropical Weather Outlook
06.07Eastern North Pacific Tropical Weather Outlook
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
More »